GlassScriptPhysician profile
Bhargava C Pulipati
NPI 1336336064
$4,647.03
in general payments reported to CMS, 2019-2025
37 companies · $815 in 2025
The $815 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $149 · 2021: $504 · 2022: $341 · 2023: $900 · 2024: $1,052 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,766.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $746.03 | 2019-2024 | Xience Sierra, Xience V, Mitraclip |
| Amgen INC. | $438.46 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $417.72 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $335.26 | 2023-2025 | Verquvo |
| Abbvie INC. | $295.98 | 2023-2025 | |
| Shockwave Medical, INC | $225.98 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $223.29 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $200.01 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $166.06 | 2025 | Avvigo Guidance System |
| Corium, LLC | $157.79 | 2022-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $152.83 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $150.01 | 2023-2025 | Camzyos, Eliquis |
| Biotronik INC. | $148.32 | 2019 | |
| Supernus Pharmaceuticals, INC. | $119.59 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.20 | 2019-2023 | Jardiance, Tradjenta |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $100.00 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $55.92 | 2022 | |
| Exact Sciences Corporation | $55.69 | 2024-2025 | Cologuard Collection Kit |
| Regeneron Healthcare Solutions, INC. | $52.04 | 2019 | |
| Daiichi Sankyo INC. | $51.17 | 2024 | Injectafer |
| Medtronic, INC. | $46.02 | 2025 | Onyx Frontier |
| Neurelis, INC. | $45.26 | 2021 | |
| Lantheus Medical Imaging, INC. | $45.10 | 2019-2025 | |
| Novo Nordisk INC | $39.44 | 2024-2025 | Wegovy, Ozempic |
| Astellas Pharma US INC | $38.57 | 2019-2020 | |
| Lilly USA, LLC | $33.96 | 2023 | Jardiance, Emgality, Synjardy |
| Pfizer INC. | $28.92 | 2019-2025 | |
| Cvrx, INC. | $27.59 | 2024 | Barostim Neo System |
| Ge Healthcare | $21.55 | 2019 | |
| Biogen, INC. | $18.67 | 2021 | |
| Celonova Biosciences, INC. | $18.52 | 2019 | |
| Edwards Lifesciences Corporation | $17.07 | 2023 | Sapien 3 Ultra Resilia |
| Arbor Pharmaceuticals, INC. | $15.55 | 2019 | |
| Medtronic Vascular, INC. | $15.39 | 2020 | |
| Amarin Pharma, INC. | $14.65 | 2019 | |
| Gilead Sciences, INC. | $12.87 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhargava Pulipati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.